Were you a child with diabetes? Or do you have one? If so, or even if you happen to be an adult effected by type 1 diabetes, it’s worth looking into the great advocacy work done by JDRF’s Children’s Congress.
I wrote about this effort once before, but felt it was a good time to re-visit the topic given that applications to participate in the 2011 Congress are due by 5 p.m. EDT on Monday,…
There were a number of encouraging news announcements this week here in Florida about progress on the JDRF’s Artificial Pancreas Project. The most prominent of those is today’s unveiling of the results of the STAR 3 Trial (Sensor-Augmented Pump Therapy for A1C Reduction) that showed adults, teens and children achieving a 4x reduction in A1C levels using this tech-heavy therapy versus patients on injections.
The STAR study, sponsored by Medtronic, was conducted at 30 clinics…
One of the common criticisms of the Juvenile Diabetes Research Foundation is its overwhelming emphasis on children and parents of children with diabetes — with little to no recognition that kids with diabetes, well… grow up. Or that ever-growing numbers of us are being diagnosed with Type 1 diabetes as adults. God knows I’ve been vocal in pestering the JDRF on this issue over the past couple of years.
Slowly, the organization has branched out,…
In the past few weeks, the diabetes community has suffered several tragedies in losing young people to diabetes. It is shocking and upsetting when diabetes takes the life of anyone, but somehow more so when it cuts a young life so short. Moira McCarthy Stanford is a journalist, a long-time JDRF volunteer and mom to Leigh, 22, and Lauren, 18 — who was diagnosed with type 1 at age 5. Today, Lauren is one of many…
Read more »
When the JDRF recently announced its newest artificial pancreas push — a partnership with Animas and Dexcom to actually develop a commercial product — head of the project Aaron Kowalski kindly agreed to answer reader questions here.
Today, I bring you those answers, direct “from the horses’ mouth,” as it were.
Usage Issues
Q) How much more advanced will this be than the Medtronic Paradigm Veo system launched in Europe, which stops insulin delivery for…